Suppr超能文献

一种用于测定小鼠血浆和组织及人血浆中苯妥英的快速灵敏的 LC-MS/MS 方法。

Rapid and sensitive LC-MS/MS method for determination of felbamate in mouse plasma and tissues and human plasma.

机构信息

Pharmacology Core Laboratory, Department of Clinical Sciences, Animal Cancer Center, Colorado State University, Fort Collins, CO 80523-1678, United States.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Dec 15;878(32):3432-6. doi: 10.1016/j.jchromb.2010.10.006. Epub 2010 Oct 16.

Abstract

Felbamate (2-phenyl-1,3-propanediol dicarbamate) is a second generation antiepileptic drug used to treat seizures refractory to other antiepileptic drugs. With approximately 3500 new patients exposed annually, several important pharmacologic interaction questions remain unanswered necessitating the need for rapid and accurate methods of felbamate analysis in biological matrices. To this end, a rapid liquid chromatography tandem mass spectrometry (LC-MS/MS) method was developed for the measurement of felbamate in mouse plasma and tissues and human plasma. Plasma (100 μL) and tissues homogenates (100 μL of 100 mg/mL) were spiked with internal standard (carisoprodol) prior to protein precipitation with acetonitrile. Samples were chromatographed on a XBridge Phenyl, 2.5 μm, 4.6 mm×50 mm column with quantitation by internal standard reference monitoring of the ion transitions m/z 239→117 for felbamate and m/z 261→176 for carisoprodol. Calibration curves were linear from 2.5 to 500 ng/mL in mouse or human plasma and 25-5000 pg/mg in tissue homogenates. Recoveries were greater than 97% for plasma and homogenates with accuracies >92% in any of the mouse matrices and >88% in human plasma. Comparable accuracies and precision were found with and without the use of the internal standard in preparation of the calibration curves and suggest that the internal standard may not be required.

摘要

苯丙二酚二氨基甲酸酯(2-苯基-1,3-丙二醇二氨基甲酸酯)是一种第二代抗癫痫药物,用于治疗对其他抗癫痫药物耐药的癫痫发作。每年约有 3500 名新患者接触该药,仍有几个重要的药物相互作用问题尚未得到解答,这需要快速准确的生物基质中苯丙二酚分析方法。为此,开发了一种快速液相色谱串联质谱(LC-MS/MS)法,用于测定小鼠血浆和组织以及人血浆中的苯丙二酚。血浆(100μL)和组织匀浆(100μL 的 100mg/mL)用乙腈沉淀蛋白前,加入内标(卡马西平)。样品在 XBridge Phenyl,2.5μm,4.6mm×50mm 柱上进行色谱分离,通过内标参考监测离子跃迁 m/z 239→117 对苯丙二酚和 m/z 261→176 对卡马西平进行定量。在小鼠或人血浆中,校准曲线的线性范围为 2.5 至 500ng/mL,在组织匀浆中为 25-5000pg/mg。在任何小鼠基质中的回收率均大于 97%,在人血浆中的回收率大于 92%,准确度均大于 88%。在制备校准曲线时使用和不使用内标均具有相似的准确度和精密度,这表明内标可能不是必需的。

相似文献

1
Rapid and sensitive LC-MS/MS method for determination of felbamate in mouse plasma and tissues and human plasma.
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Dec 15;878(32):3432-6. doi: 10.1016/j.jchromb.2010.10.006. Epub 2010 Oct 16.
2
Determination of felbamate concentration in pediatric samples by high-performance liquid chromatography.
Ther Drug Monit. 1997 Jun;19(3):301-6. doi: 10.1097/00007691-199706000-00010.
3
Totally automated analysis by robotized PrepStation and liquid chromatography: direct-sample analysis of felbamate.
Ther Drug Monit. 1996 Oct;18(5):573-80. doi: 10.1097/00007691-199610000-00009.
4
Determination of felbamate in human serum by high-performance liquid chromatography.
Ther Drug Monit. 1994 Aug;16(4):419-24. doi: 10.1097/00007691-199408000-00014.
7
Determination of the anticonvulsant felbamate and its three metabolites in brain and heart tissue of rats.
J Chromatogr. 1993 May 5;614(2):285-92. doi: 10.1016/0378-4347(93)80320-4.
8
Determination of valproate in the presence of felbamate in human plasma by narrow bore capillary gas chromatography.
Epilepsia. 1994 Mar-Apr;35(2):406-10. doi: 10.1111/j.1528-1157.1994.tb02453.x.
9
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy.
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Feb 1;878(3-4):461-5. doi: 10.1016/j.jchromb.2009.11.039. Epub 2009 Dec 3.
10
Chromatographic procedures for the determination of felbamate in serum.
J Anal Toxicol. 1995 Oct;19(6):499-503. doi: 10.1093/jat/19.6.499.

引用本文的文献

1
Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.
Korean J Physiol Pharmacol. 2011 Apr;15(2):67-81. doi: 10.4196/kjpp.2011.15.2.67. Epub 2011 Apr 30.

本文引用的文献

2
Key elements of bioanalytical method validation for small molecules.
AAPS J. 2007 Mar 30;9(1):E109-14. doi: 10.1208/aapsj0901011.
3
Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
Clin Pharmacokinet. 2006;45(11):1061-75. doi: 10.2165/00003088-200645110-00002.
4
Felbamate: consensus of current clinical experience.
Epilepsy Res. 2006 Oct;71(2-3):89-101. doi: 10.1016/j.eplepsyres.2006.06.020. Epub 2006 Aug 4.
5
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy.
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Dec 15;828(1-2):113-7. doi: 10.1016/j.jchromb.2005.09.009. Epub 2005 Sep 22.
7
Population pharmacokinetics of felbamate in children.
Ther Drug Monit. 1997 Feb;19(1):29-36. doi: 10.1097/00007691-199702000-00005.
9
Felbamate-associated fatal acute hepatic necrosis.
Neurology. 1996 May;46(5):1457-9. doi: 10.1212/wnl.46.5.1457.
10
Felbamate therapy in the Lennox-Gastaut syndrome.
N Engl J Med. 1993 Jun 3;328(22):1641. doi: 10.1056/nejm199306033282216.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验